Metropolitan Life Insurance Company (MetLife)’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-6,038
| Closed | -$32.4K | – | 1003 |
|
|
2024
Q1 | $32.4K | Sell |
6,038
-1,644
| -21% | -$8.83K | ﹤0.01% | 1624 |
|
|
2023
Q4 | $38.6K | Buy |
7,682
+1,622
| +27% | +$8.14K | ﹤0.01% | 1588 |
|
|
2023
Q3 | $10.2K | Hold |
6,060
| – | – | ﹤0.01% | 2194 |
|
|
2023
Q2 | $16.8K | Buy |
6,060
+1,470
| +32% | +$4.09K | ﹤0.01% | 2020 |
|
|
2023
Q1 | $8.35K | Sell |
4,590
-363
| -7% | -$661 | ﹤0.01% | 2219 |
|
|
2022
Q4 | $25.1K | Hold |
4,953
| – | – | ﹤0.01% | 1884 |
|
|
2022
Q3 | $24.6K | Buy |
4,953
+3,109
| +169% | +$15.5K | ﹤0.01% | 1913 |
|
|
2022
Q2 | $6.86K | Sell |
1,844
-2,805
| -60% | -$10.4K | ﹤0.01% | 2332 |
|
|
2022
Q1 | $26.1K | Sell |
4,649
-14,225
| -75% | -$79.8K | ﹤0.01% | 1964 |
|
|
2021
Q4 | $115K | Sell |
18,874
-329
| -2% | -$2K | ﹤0.01% | 2394 |
|
|
2021
Q3 | $187K | Hold |
19,203
| – | – | ﹤0.01% | 2130 |
|
|
2021
Q2 | $274K | Buy |
19,203
+9,732
| +103% | +$139K | ﹤0.01% | 1930 |
|
|
2021
Q1 | $225K | Sell |
9,471
-300
| -3% | -$7.12K | ﹤0.01% | 1936 |
|
|
2020
Q4 | $130K | Hold |
9,771
| – | – | ﹤0.01% | 2213 |
|
|
2020
Q3 | $67.8K | Hold |
9,771
| – | – | ﹤0.01% | 2417 |
|
|
2020
Q2 | $120K | Buy |
+9,771
| New | +$120K | ﹤0.01% | 2139 |
|
|
2017
Q3 | – | Sell |
-23,692
| Closed | -$180K | – | 2496 |
|
|
2017
Q2 | $180K | Buy |
+23,692
| New | +$180K | ﹤0.01% | 2399 |
|